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SUMMARY 
 
What is known and objectives: Paracetamol is a frequently used antipyretic and 
analgesic drug, but also a dose-dependent hepatotoxin. Unintentional paracetamol 
overdosing is a common medication error in hospitals. The present study aimed at 1) 
Analysis of unintentional paracetamol overdosing in hospitalized patients; 2) 
Development, implementation and outcome of an alert algorithm for the prevention of 
considerable paracetamol overdosing. 
Methods: All patients who received paracetamol in a Swiss tertiary care hospital 
during 2011 to 2014 were analysed to detect cases of paracetamol overdosing in a 
local pharmacoepidemiological database. In 2014 an algorithm screened the 
hospital’s electronic prescribing system for patients at risk of considerable 
overdosing, followed by expert validation. When such overdosing was confirmed as 
imminent, alerts were issued to prescribers. Considerable overdosing was defined as 
prescriptions that permitted repeated daily paracetamol exposure of ≥ 5 g. 
Results and Discussion: From 2011 to 2013 considerable overdosing occurred in 
11 patients (5 - 8 g / d for 3 to 5 days), which corresponds to 0.4 % of all patients 
exposed to any paracetamol overdosing (mean n = 988 per year). In 2014 alerts 
were issued by experts in 23 cases with subsequent changes to prescriptions in 21 
(91.3 %) thereof. While the occurrence of any paracetamol overdosing declined only 
marginally in 2014 (n = 914), no considerable overdosing occurred anymore. 
What is new and Conclusion: This proof of concept demonstrates that analyzing 
local hospital data allows the development of alert algorithms that successfully 
prevent relevant medication errors. Unintentional paracetamol overdosing was 
frequent but thereof only a small fraction was deemed considerable. The presented 
intervention achieved a high compliance and prevented this medication error.  
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INTRODUCTION 
Paracetamol has analgesic and antipyretic properties and is one of the most 
frequently used drugs worldwide. If administered within labelled doses of no more 
than 4 g per day severe adverse effects are very rare, but if recommended doses are 
exceeded it is also an intrinsic hepatotoxin.(1) Toxicity is enhanced in patients with 
cachexia or alcoholism and with repeated overdosing.(2, 3) Because of its over-the-
counter availability and frequent use intentional and unintentional paracetamol 
overdosing is common in clinical practice, and paracetamol-induced liver failure is 
indeed the leading cause of liver transplantations in the US.(1, 4) Zhou and 
colleagues recently investigated the frequency of unintentional paracetamol 
overdosing in a tertiary care hospital and reported that 6.6% of paracetamol users 
exceeded the recommended maximum dose of 4 g per day.(5) Civan et al. performed 
a similar analysis and reported overdosing in 2.6%.(6) 
In hospitals that use clinical information systems (CIS) with computerized physician 
order entry (CPOE) all prescriptions are electronically documented, and integrated 
clinical decision support systems (CDSS) may in theory detect and prevent many 
medication errors including paracetamol overdosing.(7, 8) However, in clinical 
practice automated alerts from CDSS are mostly oversensitive and clinically 
irrelevant.(9, 10) Such over-alerting without clinical implications may lead to alert 
fatigue and ultimately to indiscriminate alert overriding or deactivation of the 
CDSS.(11) For an effective prevention of paracetamol overdosing, alerts should 
therefore only be issued in clinically relevant situations, i.e. when they imply a 
considerable risk of adverse events and require the prescriber to take action.(12) 
Therefore the present study aimed to quantify considerable paracetamol overdosing 
and to develop, implement and evaluate the outcome of a specific preventive alert 
algorithm. 
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METHODS 
We analysed paracetamol overdosing occurring in a Swiss tertiary care hospital with 
about 1,000 beds and 40 clinical specialty divisions. For all retrospective analyses of 
paracetamol overdosing we used our previously described pharmacoepidemiological 
database containing information on demographics, laboratory results and electronic 
drug prescriptions extracted on single patient-level from the hospital’s CIS.(13) Of 
note, the hospitals CIS (KISIM by Cystec AG) features not only prescriptions, but 
also a confirmation for each drug’s actual administration including its time.(14) The 
cantonal ethics committee, the hospital’s medical director and the hospital’s centre 
for clinical research had approved the extraction of anonymized patient data, setup of 
a pharmacoepidemiological database and analysis, and the access to patients’ 
original medical records for research purposes. We developed and validated an 
algorithm for the identification of patients with confirmed paracetamol administrations 
of > 4 g per day and compared the time periods from 1 Jan 2011 until 31 Dec 2013 
(before implementation of an alert system) vs. 1 Jan to 31 Dec 2014 (after 
implementation of an alert system). By reviewing comprehensive electronic medical 
records of patients with ≥ 2 subsequent days of overdosing the following additional 
information was compiled: number, dose, route of administration and Anatomical 
Therapeutic Chemical Classification System code (ATC-code) of prescribed and 
administered paracetamol containing products, cachexia, alcoholism, laboratory 
results of alanine amino transaminase (ALT) before and after exposure to overdose 
and other signs and symptoms of paracetamol-induced liver injury. 
For the prevention of paracetamol overdosing we developed an algorithm within the 
hospitals CIS that identified patients at risk of considerable paracetamol overdosing. 
The algorithm was implemented in 2014 and allowed local safety experts at the 
Department of Clinical Pharmacology an on-demand identification of any patient with 
confirmed administrations of > 4 g paracetamol per calendar-day. For this, a program 
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based on Oracle Instant Client developed by the hospitals’ IT department accessed 
the CIS and extracted the amount of paracetamol of any administered drug within the 
last calendar-day, i.e. 1 May 0:00 to 1 May 23:59.(15) This raw data was then used 
to calculate the total amount of paracetamol patients had received using STATA 
software.(16) Patients identified as receiving > 4 g were then validated through 
review of their electronic medical records and additional information as described 
above was compiled including information on prescriptions of paracetamol that were 
not (yet) administered, e.g. drugs prescribed ‘as needed’. 
Based on the results from retrospective analyses and currently available literature we 
classified administrations of ≥ 5 g per day for ≥ 3 subsequent days as a threshold for 
considerable overdosing, i.e. clinicians should take action before patients are 
exposed to such an overdose. For patients suffering from cachexia or alcoholism a 
lower threshold was chosen, their prescribers were alerted immediately after any 
administration of > 4 g / day. If our review confirmed a potential for considerable 
overdosing we notified prescribing physicians through internal email and if 
appropriate also through personal phone calls. These internal emails featured the 
cause of overdosing, e.g. a parallel administration of paracetamol p.o. and i.v. and a 
short quote of the products SPC regarding dosing in patients suffering from cachexia 
or alcoholism. Subsequent changes to paracetamol prescriptions were recorded. 
 
RESULTS AND DISCUSSION 
For the time period of 2011 to 2013, i.e. before implementation of the alert system, 
we identified 49,357 individual patients with at least one paracetamol administration 
during hospitalization. Among all paracetamol users 2,965 patients (6.01 %) were 
exposed to at least one day with administration of > 4 g paracetamol per day. 
Repeated overdosing with ≥ 5 g for ≥ 2 consecutive days occurred in 38 patients, and 
among these 4 suffered from cachexia and 2 of current alcoholism. Considerable 
Page 6 of 11 
overdosing with administrations of 5 to 8 g paracetamol per day for up to 5 
consecutive days had occurred in 11 patients. Alanine aminotransferase (ALT) 
values before and after exposure to considerable overdosing were available for 9 of 
those patients. In one patient ALT after overdosing exceeded three times the upper 
limit of normal. In this case, clinicians suspected paracetamol as a cause and 
stopped its administration after exposing this cachectic patient to 5 g paracetamol for 
three consecutive days. 
In 2014 our proactive alert system was implemented and 19,589 individual patients 
received at least one paracetamol administration during hospitalization. Thereof 914 
(4.67%) were exposed to at least one day with administration of > 4 g per day. The 
our alert system identified on average 3 patients per day that were exposed to more 
than 4 g of paracetamol per day. These were subject to timely review of their 
electronic medical records at the early morning of the following day. The assessment 
whether considerable overdosing was imminent took usually less than 5 minutes per 
patient. Alerts with recommendations to change current paracetamol prescriptions 
were issued for 23 patients during one year. In 21 of these cases (91.3%) prescribing 
physicians were compliant with our recommendations and changed paracetamol 
prescriptions accordingly on the same day as the alert was issued. An additional 8 
alerts were issued for patients with presence of cachexia or alcoholism for which a 
maximum dose of 3 g per day was recommended. In 6 of those cases prescription 
were adapted accordingly. Following the implementation of proactive alerts 
considerable paracetamol overdosing of ≥ 5 g per day for more than two days did not 
occur anymore in 2014. Study design and results are presented in Figure 1. 
Paracetamol overdosing is a ubiquitous and frequent medication error. In fact the 
proportion of patients that were exposed to more than 4 g paracetamol during their 
hospitalization was 6.0% in our setting and therefore almost identical to the number 
reported by Zhou et al. in a similar setting in the US.(5) However, a single day with 
administration of only little more than 4 g paracetamol, although a formal medication 
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error, is usually irrelevant. In order to avoid alert fatigue proactive  safety systems 
therefore have to find an alerting threshold for medication errors that are relevant and 
require prescription changes. Indeed, our further analyses confirmed that the majority 
of paracetamol overdosing is not repeated and during three years we did not identify 
a single case of paracetamol-induced liver injury. Typically, overdosing occurs only 
once per patient and was caused by early administration of a dose actually 
scheduled for the next day or overlapping administrations when the route of 
administration was changed from oral- to i.v. or vice versa. Another at risk scenario 
occurs when multiple paracetamol-containing drugs are prescribed concomitantly, or 
when there are fixed-dose plus on-demand prescriptions of paracetamol. On the 
other hand unintentional iatrogenic paracetamol hepatotoxicity and even liver failure 
has been described and justifies preventive measures.(1) Because of the rarity of 
such events preventive measures must be efficient but also highly specific in order to 
assure physicians’ compliance with alerts. 
We therefore chose a pragmatic solution, i.e. an automated sensitive screening was 
followed by specific manual evaluations. Our experience with this system shows that 
once installed the necessary resources for review of prescribed overdose are 
minimal and that considerable paracetamol overdosing did not occur any more after 
the implementation of our safety system in 2014. 
 
WHAT IS NEW AND CONCLUSION 
We cannot formally prove that our program was the exclusive cause for the absence 
of considerable paracetamol overdosing. Yet our alert program may have had an 
additional effect on the prescribing behaviour regarding paracetamol. Our alert 
program was is part of a proactive and open drug safety culture and can serve as a 
proof-of-concept not only regarding considerable paracetamol overdosing but also for 
the prevention of other suitable medication errors. Such semi-automated safety 
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programs can be implemented in clinical routine of any hospital with a CIS, IT 
specialists and clinical drug safety experts. 
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